CSBR vs DD · P/E 16, rev $56.9M vs P/E 127, rev $12.39B
Champions Oncology Inc (CSBR) versus Dupont De Nemours Inc (DD) — a side-by-side from cached financials, not a winner call.
Champions Oncology Inc (CSBR) is a biotechnology company listed on US.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
Latest reported CSBR revenue for 2025-04-30 was $56.9M. Net income was $4.7M. CSBR currently screens at market cap $99.8M and trailing P/E 16.0.
Latest reported DD revenue for 2024-12-31 was $12.39B. Net income was $738.0M. Revenue was up 2.6% from 2023-12-31 to 2024-12-31. DD currently screens at market cap $19.61B and trailing P/E 127.4.
CSBR currently screens at market cap $99.8M and trailing P/E 16.0. DD currently screens at market cap $19.61B and trailing P/E 127.4.
Not investment advice. Open the CSBR and DD stock pages for the full models.
Not investment advice.